Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

Critical Care

Volumn 9, Issue 1, 2005, Pages 29-30

  Mubareka, Samira ^a   Rubinstein, Ethan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Acinetobacter; Colistin; Gram negative; Nosocomial; Pneumonia; Resistant

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORINASE; COLISTIMETHATE; COLISTIN; HYDROLASE; POLYMYXIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AEROSOL; ARTICLE; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; BRONCHOSPASM; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG PENETRATION; ERADICATION THERAPY; GENERAL CONDITION IMPROVEMENT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION RISK; KIDNEY DYSFUNCTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NEBULIZATION; NEPHROTOXICITY; NEUROMUSCULAR BLOCKING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; SIDE EFFECT; THORAX PAIN; THROAT DISEASE;

AEROSOLS; ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; PNEUMONIA; RETROSPECTIVE STUDIES;

EID: 13844299401     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3036     Document Type: Article

References (8)

1. Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J: Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 2003, 31:2478-2482.
2. Van Looveren M, Goosens H, AARPAC Steering Group: Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004, 10:684-704.
3. Jain R, Danziger LH: Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 2004, 38:1449-59.
4. Beringer P: The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulmonary Med 2001, 7:434-440.
5. Evans ME, Feola DJ, Rapp RP: Polymixin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria. Ann Pharmacother 1999, 33:960-967.
6. Westerman EM, Le Brun PPH, Touw DJ, Frijlink HW, Heijerman HGM: Effect of nebulized colistin sulphate and colistin sulphomethate on fung function in patients with cystic fibrosis: a pilot study. J Cystic Fibrosis 2004, 3:23-28.
7. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME: Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005, 9:R53-R59.
8. Kollef MH: Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004, 32: 1396-1405.